Oridonin alleviates hyperbilirubinemia through activating LXR alpha-UGT1A1 axis

Zhan, ZK; Dai, FH; Zhang, T; Chen, YL; She, JL; Jiang, HG; Liu, SW; Gu, TW; Tang, L

Tang, L (通讯作者),Southern Med Univ, Sch Pharmaceut Sci, NMPA Key Lab Res & Evaluat Drug Metab, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China.

PHARMACOLOGICAL RESEARCH, 2022; 178 ():

Abstract

Hyperbilirubinemia is a serious hazard to human health due to its neurotoxicity and lethality. So far, successful therapy for hyperbilirubinemia with ......

Full Text Link